Supplemental material
Modern Rheumatology
Volume 29, 2019 - Issue 5
Open access
3,415
Views
16
CrossRef citations to date
0
Altmetric
Original Article
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
Masayoshi HarigaiDivision of Epidemiology and Pharmacoepidemiology, Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan; Correspondence[email protected]
, Naoki IshiguroGraduate School & Faculty of Medicine, Nagoya University School of Medicine, Nagoya, Japan;
, Shigeko InokumaChiba Central Medical Center, Chiba, Japan;
, Tsuneyo MimoriKyoto University Graduate School of Medicine, Kyoto, Japan;
, Junnosuke RyuNihon University School of Medicine, Tokyo, Japan;
, Syuji TakeiFaculty of Medicine, Kagoshima University School of Health Science, Kagoshima, Japan;
, Tsutomu TakeuchiKeio University School of Medicine, Tokyo, Japan;
, Yoshiya TanakaUniversity of Occupational and Environmental Health, Fukuoka, Japan;
, Yoshinari TakasakiJuntendo University School of Medicine, Tokyo, Japan;
, Hisashi YamanakaDivision of Epidemiology and Pharmacoepidemiology, Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;
, Yuri YoshizawaBristol-Myers Squibb K.K., Tokyo, Japan;
, Ichino ChinenBristol-Myers Squibb K.K., Tokyo, Japan;
, Toru NakaoBristol-Myers Squibb K.K., Tokyo, Japan;
& Takao KoikeSapporo Medical Center NTT EC, Sapporo, Japan
show all
Pages 747-755
|
Received 20 Jun 2018, Accepted 08 Sep 2018, Published online: 25 Oct 2018
Related Research Data
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
Source:
Informa UK Limited
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
Source:
Informa UK Limited
Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs
Source:
Springer Nature
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
Source:
The Journal of Rheumatology
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology’s ORA registry
Source:
Oxford University Press (OUP)
Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study
Source:
The Journal of Rheumatology
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
Source:
Taylor & Francis
Longterm Efficacy and Safety of Abatacept in Patients with Rheumatoid Arthritis Treated in Routine Clinical Practice: Effect of Concomitant Methotrexate after 24 Weeks
Source:
The Journal of Rheumatology
Therapeutic criteria in rheumatoid arthritis.
Source:
American Medical Association (AMA)
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Source:
Oxford University Press (OUP)
MODIFIED DISEASE ACTIVITY SCORE
Source:
Wiley
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Source:
Informa UK Limited
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis
Source:
BMJ
Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis
Source:
Informa UK Limited
The efficacy of abatacept in Japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice
Source:
Informa UK Limited
Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study
Source:
The Journal of Rheumatology
Longterm Retention Rate and Risk Factor for Discontinuation Due to Insufficient Efficacy and Adverse Events in Japanese Patients with Rheumatoid Arthritis Receiving Etanercept Therapy
Source:
The Journal of Rheumatology
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
Source:
Informa UK Limited
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.